Cargando…

Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser

Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Geun, Ryu, Hwa Jung, Kim, Il-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252676/
https://www.ncbi.nlm.nih.gov/pubmed/25473231
http://dx.doi.org/10.5021/ad.2014.26.6.755
_version_ 1782347188912783360
author Lee, Sang Geun
Ryu, Hwa Jung
Kim, Il-Hwan
author_facet Lee, Sang Geun
Ryu, Hwa Jung
Kim, Il-Hwan
author_sort Lee, Sang Geun
collection PubMed
description Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal coagulation treatment with a 1,444-nm Nd:YAG laser may be the least invasive and most effective therapy for axillary osmidrosis. However, according to our previous experience, the recurrence rate was 20%~30%. This emphasizes the need for combination of surgical method and non-surgical method and we combined subcutaneous tissue removal and photothermocoagulation with a 1,444-nm Nd:YAG laser. Three patients for bilateral axillary osmidrosis were enrolled. After an incision of about one-third the length of the widest transverse diameter, the apocrine glands were separated from the skin. And then apocrine glands within the marked area were destroyed by irradiation with a 1,444-nm Nd:YAG laser thereafter. All patients exhibited no relapse of axillary osmidrosis and were satisfied with the treatment results. A combination of subcutaneous tissue removal and Interstitial laser photothermocoagulation with a 1,444-nm Nd:YAG laser could be an effective treatment for mild to moderate axillary osmidrosis.
format Online
Article
Text
id pubmed-4252676
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-42526762014-12-03 Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser Lee, Sang Geun Ryu, Hwa Jung Kim, Il-Hwan Ann Dermatol Case Report Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal coagulation treatment with a 1,444-nm Nd:YAG laser may be the least invasive and most effective therapy for axillary osmidrosis. However, according to our previous experience, the recurrence rate was 20%~30%. This emphasizes the need for combination of surgical method and non-surgical method and we combined subcutaneous tissue removal and photothermocoagulation with a 1,444-nm Nd:YAG laser. Three patients for bilateral axillary osmidrosis were enrolled. After an incision of about one-third the length of the widest transverse diameter, the apocrine glands were separated from the skin. And then apocrine glands within the marked area were destroyed by irradiation with a 1,444-nm Nd:YAG laser thereafter. All patients exhibited no relapse of axillary osmidrosis and were satisfied with the treatment results. A combination of subcutaneous tissue removal and Interstitial laser photothermocoagulation with a 1,444-nm Nd:YAG laser could be an effective treatment for mild to moderate axillary osmidrosis. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2014-12 2014-11-26 /pmc/articles/PMC4252676/ /pubmed/25473231 http://dx.doi.org/10.5021/ad.2014.26.6.755 Text en Copyright © 2014 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lee, Sang Geun
Ryu, Hwa Jung
Kim, Il-Hwan
Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title_full Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title_fullStr Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title_full_unstemmed Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title_short Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser
title_sort minimally invasive surgery for axillary osmidrosis using a combination of subcutaneous tissue removal and a 1,444-nm nd:yag laser
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252676/
https://www.ncbi.nlm.nih.gov/pubmed/25473231
http://dx.doi.org/10.5021/ad.2014.26.6.755
work_keys_str_mv AT leesanggeun minimallyinvasivesurgeryforaxillaryosmidrosisusingacombinationofsubcutaneoustissueremovalanda1444nmndyaglaser
AT ryuhwajung minimallyinvasivesurgeryforaxillaryosmidrosisusingacombinationofsubcutaneoustissueremovalanda1444nmndyaglaser
AT kimilhwan minimallyinvasivesurgeryforaxillaryosmidrosisusingacombinationofsubcutaneoustissueremovalanda1444nmndyaglaser